Literature DB >> 11870153

Cardiac dysfunction in the trastuzumab clinical experience.

James Speyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870153     DOI: 10.1200/JCO.2002.20.5.1156

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, Canada.

Authors:  Moira Rushton; Coralea Kappel; Isac Lima; Meltem Tuna; Kathleen Pritchard; Steven Hawken; Susan Dent
Journal:  Front Cardiovasc Med       Date:  2022-05-19

2.  The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure.

Authors:  Magdalena Hulanicka; Magdalena Garncarz; Marta Parzeniecka-Jaworska; Michał Jank
Journal:  BMC Genomics       Date:  2014-06-21       Impact factor: 3.969

3.  Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer.

Authors:  Shabrina S Ghaissani; Senja R Kinanti; Muhammad A Warisman; N Fitria
Journal:  J Genet Eng Biotechnol       Date:  2021-01-11

4.  Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.

Authors:  S Gori; M Colozza; A M Mosconi; E Franceschi; C Basurto; R Cherubini; A Sidoni; A Rulli; C Bisacci; V De Angelis; L Crinò; M Tonato
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

5.  Relationship between clinical data and gene expression in the HER2/ErbB2-dependent signaling pathway in patients with acute heart failure.

Authors:  Sebastian Szmit; Michał Jank; Henryk Maciejewski; Paweł Balsam; Magdalena Łój; Krzysztof J Filipiak; Tomasz Motyl; Grzegorz Opolski
Journal:  J Appl Genet       Date:  2013-08-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.